Rare diseases
Investigational molecules
Locations
126 East Lincoln Avenue, 07065-4607, United States
Acceleron Pharma Inc. demonstrates significant engagement in addressing hematological conditions, with particular emphasis on disorders affecting red blood cell production and function. The company's research portfolio encompasses investigations into myelodysplastic syndromes and various forms of anemia that impact patient quality of life and overall health outcomes.
The therapeutic focus extends to understanding the underlying mechanisms of ineffective erythropoiesis and developing targeted interventions for patients with transfusion-dependent conditions. Research efforts concentrate on novel approaches to restore normal hematopoietic function and reduce the clinical burden associated with chronic blood disorders.
Acceleron Pharma Inc. runs clinical trials in conditions such as Pulmonary arterial hypertension, Pulmonary hypertension, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BelgiumBelgium
AustriaAustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
